Corcept Therapeutics Inc (CORT)
52.17
+1.27
(+2.50%)
USD |
NASDAQ |
Dec 24, 16:00
Corcept Therapeutics Free Cash Flow: 142.60M for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| ADMA Biologics Inc | 78.82M |
| Catalyst Pharmaceuticals Inc | 221.79M |
| Madrigal Pharmaceuticals Inc | -438.32M |
| Alnylam Pharmaceuticals Inc | 16.06M |
| Ionis Pharmaceuticals Inc | -374.21M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 73.83M |
| Cash from Investing (Quarterly) | -44.04M |
| Cash from Financing (Quarterly) | -21.09M |
| Free Cash Flow Per Share (Quarterly) | 0.6348 |
| Free Cash Flow to Equity (Quarterly) | 72.19M |
| Free Cash Flow to Firm (Quarterly) | 72.19M |
| Free Cash Flow Yield | 2.45% |